Request Demo
Last update 10 Dec 2025
KSD-101
Last update 10 Dec 2025
Overview
Basic Info
Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms Autologous monocyte-derived DCs pulsed withEBV-associated antigen(Zhongshan Hengsai) |
Target |
Action inhibitors |
Mechanism EBV Protein inhibitors |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with KSD-101NCT06752473
KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
NCT06370026
KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
NCT06097793
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
100 Clinical Results associated with KSD-101
Login to view more data
100 Translational Medicine associated with KSD-101
Login to view more data
100 Patents (Medical) associated with KSD-101
Login to view more data
100 Deals associated with KSD-101
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epstein-Barr virus associated Nasopharyngeal Carcinoma | Phase 1 | China | 04 Dec 2023 | |
| Epstein-Barr Virus-Related Lymphoma | Phase 1 | China | 10 Jun 2023 | |
| Hematologic Neoplasms | Phase 1 | China | - | 16 Jan 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05635591 (ASCO2025) Manual  | Phase 1 | 11 | hrduwihqro(dhkotoniru) = ygbxtanxpe fypvvbwlhh (tkwrtrtjqq ) View more | Positive | 30 May 2025 | ||
Phase 1 | 9 | wbyqqozwuu(jxuskfklzm) = vezwnwzlek fzqiolohhq (vhtffwpfyo ) View more | Positive | 14 May 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free